On August 27, HENGRUI PHARMA rose 3.04% in regular trading, trading at 48.12 HKD/share, with turnover of HKD 478 million.

On the news front, Hong Kong Exchange disclosures revealed that Singapore sovereign wealth fund GIC Private Limited conducted consecutive stake increases on August 20 and August 21, purchasing 3.66 million shares at approximately 50.57 HKD per share and 3.84 million shares at approximately 48.15 HKD per share, respectively. The total investment amounted to approximately HKD 370 million. Following the purchases, GIC's holding in the company rose from 14.29% to 17.19%, totaling 44.39 million shares.

Additionally, the company disclosed an A-share buyback plan on August 26, with a spending cap of RMB 2 billion at a maximum price of 81.78 yuan per share, with repurchased shares designated for an employee stock ownership plan. The buyback is to be completed within 12 months. Separately, JPMorgan's short position in the stock increased to 3.72% from 2.57% as of August 21, reflecting mixed institutional positioning.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)